Recently, several lncRNAs, including brain Cytoplasmic RNA 1 (BCYRN1), have been reported to be associated with tumor progression, metastasis, and acquired anticancer drug resistance [34,35,36,37]. The gene discussed is BCYRN1; the disease is neoplasm.